Publication | Closed Access
A monoclonal antibody discriminating between subsets of T and B cells.
549
Citations
0
References
1981
Year
The rat monoclonal antibody JIId binds erythrocytes, neutrophils, most thymus cells, and the majority of B cells. It shows no activity against mature T cells, stem cells, platelets, or monocytes, but is expressed on 90–95 % of small B lymphocytes and IgG‑producing cells, and its binding diminishes primary IgM and lipopolysaccharide‑induced proliferation while leaving secondary IgG responses unaffected.
Abstract A description is given of a rat anti-mouse hybridoma antibody, JIId, which reacts with erythrocytes, neutrophils, greater than 90% of thymus cells, and most B cells. JIId does not have detectable activity for mature T cells, pluripotential stem cells, platelets, or cells of the monocyte-macrophage lineage. Although the JIId antigen is present on 90 to 95% of typical small B lymphocytes, pretreatment of spleen cells with JIId plus complement has no effect on secondary IgG antibody responses; by contrast, primary IgM responses and proliferative responses to lipopolysaccharide are substantially reduced. Unlike the precursors of IgG antibody-producing cells (AFC), IgG AFC per se are strongly JIId-positive. Rapid acquisition of the JIId antigen also applied to the early progeny of pluripotential stem cells.